Errors in Key Points, Abstract, Results, Table 2, and Conflict of Interest Disclosures
Abstract
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical industry and healthcare · Medical Malpractice and Liability Issues · Healthcare cost, quality, practices
In the Original Investigation titled “Implementing Accuracy, Completeness, and Traceability for Data Reliability,”^1^ published March 10, 2025, the respective percentage values in Key Points given as 46.7% and 95.6% should have been 46.1% and 96.6%. In the Abstract Results, main article Results, and Table 2, the upper bound of the 95% CI given as 1.1% for advanced completeness should have been 107.4%. In the Conflict of Interest Disclosure for Dr Bradbury, the phrase “other from Verantos Inc during the conduct of the study” should have been removed. This article was corrected.^1^
The reference list from the paper itself. Each links out to its DOI / PubMed record.